Chaihu‐Guizhi Decoction Attenuates Airway Remodelling in COPD Mice via the TGF‐β1/Smads Signalling Pathway: An Integrated Proteomic and Metabolomic Analysis
Biomedical Chromatography · 2026-12 · 40 (12)
DOI: 10.1002/bmc.70632 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 20.10.2026. Verfasst von Jiuwang Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hohhot Hospital of Traditional Chinese Medicine and Mongolian Medicine, Hohhot, Inner Mongolia, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Pulmonary Disease, Chronic Obstructive, Transforming Growth Factor beta1, Smad Proteins. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Hohhot Municipal Health and Science Technology Plan Project, China Association for Science and Technology, Hohhot Basic Research and Applied Basic Research Project.
Themen: COPD
Abstract (Originalsprache)
Chronic obstructive pulmonary disease (COPD) is characterised by persistent airway injury and remodelling, and the mechanisms by which Chai‐Hu‐Gui‐Zhi Decoction (CGD) acts in COPD remain unclear. This study investigated whether CGD attenuates airway remodelling through the TGF‐β1/Smads–EMT–ECM signalling axis. A mouse COPD model was established by cigarette‐smoke exposure plus intranasal lipopolysaccharide. After model induction, mice received dexamethasone acetate or low‐, medium‐ or high‐dose CGD for 28 days. UHPLC‐MS/MS, network pharmacology, molecular docking, molecular dynamics, proteomics, metabolomics, ELISA, western blotting, RT‐PCR, pulmonary function testing and histopathology were integrated. CGD dose‐dependently improved pulmonary function and lung pathology and reduced BALF total protein, NO, VEGF, IFN‐γ, MPO, CXCL1 and serum 8‐OHdG. Multi‐omics and network analyses implicated phenylalanine/tyrosine/tryptophan biosynthesis, the histidine–glutamate–hypoxanthine axis, MAPK, PI3K–Akt and TGF‐β1‐related pathways. Validation showed that CGD decreased TGF‐β1, p‐SMAD2/3, SMAD2/3, MMP‐9 and TIMP‐1; increased SMAD7 and E‐cadherin; and regulated Smad2/Smad3/Smad7 mRNA. CGD may attenuate COPD airway remodelling, in association with suppressed TGF‐β1/Smads signalling, restored SMAD7‐mediated feedback, limited EMT and rebalanced ECM remodelling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hohhot Hospital of Traditional Chinese Medicine and Mongolian Medicine, Hohhot, Inner Mongolia, China.
ORCID-Profile: Yuping Zhang
Förderung
- Hohhot Municipal Health and Science Technology Plan Project
- China Association for Science and Technology
- Hohhot Basic Research and Applied Basic Research Project
- Natural Science Foundation of Inner Mongolia Autonomous Region
Zitieren
APA
Yu, J., Wu, X., Chen, Z., Zhai, C., A, J., & Zhang, Y. (2026). Chaihu‐Guizhi Decoction Attenuates Airway Remodelling in COPD Mice via the TGF‐β1/Smads Signalling Pathway: An Integrated Proteomic and Metabolomic Analysis. Biomedical Chromatography, 40(12). https://doi.org/10.1002/bmc.70632
Vancouver
Yu J, Wu X, Chen Z, Zhai C, A J, Zhang Y. Chaihu‐Guizhi Decoction Attenuates Airway Remodelling in COPD Mice via the TGF‐β1/Smads Signalling Pathway: An Integrated Proteomic and Metabolomic Analysis. Biomedical Chromatography. 2026;40(12). doi:10.1002/bmc.70632
BibTeX
@article{Yu2026,
author = {Yu, Jiuwang and Wu, Xiaodong and Chen, Zeyu and Zhai, Chenxu and A, Jinxiang and Zhang, Yuping},
title = {Chaihu‐Guizhi Decoction Attenuates Airway Remodelling in COPD Mice via the TGF‐β1/Smads Signalling Pathway: An Integrated Proteomic and Metabolomic Analysis},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {12},
doi = {10.1002/bmc.70632}
}
EUVIMED